Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021)

Insight Molecular Diagnostics' (IMDX) quarterly Tax Provisions came in at -$97000.0 in Q4 2021, down 161.01% year-on-year from $159000.0 in Q4 2020, and up 94.59% quarter-over-quarter from -$1.8 million in Q2 2021.

Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021) Analysis & Trends

Insight Molecular Diagnostics has disclosed Tax Provisions across 2 years of filings, most recently posting -$97000.0 for Q4 2021.

  • Tax Provisions for Q4 2021 came in at -$97000.0, down 161.01% year-over-year; the trailing twelve-month figure through Sep 2024 was -$97000.0 (changed N/A YoY), and the FY2022 annual result was -$8.1 million, up 12.9% from the prior year.
  • Tax Provisions came in at -$97000.0 for Q4 2021 at Insight Molecular Diagnostics, up from -$1.8 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1.1 million in Q1 2020 to a low of -$7.6 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn -16.00 Mn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn 70.00 Mn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn 206.00 Mn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn 77.00 Mn
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn 69.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn 59.00 Mn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn 300,000.00
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn 23.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn 40.20 Mn
10 Insight Molecular Diagnostics 4.34 Mn -24.59 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2021 -97,000.00
Jun 30, 2021 -1.79 Mn
Mar 31, 2021 -7.56 Mn
Dec 31, 2020 159,000.00
Jun 30, 2020 -2.19 Mn
Mar 31, 2020 1.10 Mn